Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.38 +0.20 (+6.29%)
At close: Sep 29, 2026 · 4:00 PM EDT

Insight Molecular Diagnostics (IMDX) Operating Leases (2018 - 2023)

Updated

Insight Molecular Diagnostics' Operating Leases was $2.1 million in Q4 2023, down 23.0% from $2.73 million a year earlier and down 10.7% from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) Operating Leases (2018 - 2023) Analysis & Trends

From Q4 2018 onward, Insight Molecular Diagnostics has reported Operating Leases for 9 quarters.

  • Operating Leases shows a five-year compound annual growth rate of 62.2% (FY2018 to FY2023).
  • In earlier years, Operating Leases was $2.73 million in FY2022 and $2.68 million in FY2019.
  • The Q4 2023 figure marks the lowest quarterly Operating Leases since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 Insight Molecular Diagnostics 103.74 Mn 27.46 Mn 157,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2.10 Mn
Sep 30, 2023 2.35 Mn
Jun 30, 2023 2.40 Mn
Dec 31, 2022 2.73 Mn
Sep 30, 2020 3.87 Mn
Jun 30, 2020 3.11 Mn
Mar 31, 2020 3.10 Mn
Dec 31, 2019 2.68 Mn
Dec 31, 2018 187,000.00
API Access

Insight Molecular Diagnostics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=IMDX&period=max&api_key=YOUR_API_KEY